Results 21 to 30 of about 161,071 (201)

Interleukin 1-β, Interleukin-1 Receptor Antagonist, and Interleukin 18 in Children with Acute Spontaneous Urticaria [PDF]

open access: yes, 2013
Very little is known about the role of interleukin-1β (IL-1β) and interleukin-18 (IL-18) in urticaria. Material and Methods. Serum levels of IL-1β, IL-1 receptor antagonist (IL-1RA), and IL-18 were measured in 56 children with urticaria and in 41 healthy
A. Kasperska-Zając   +4 more
core   +1 more source

Evaluation of the Interleukin-1 Receptor Antagonist and Immunoregulatory Interleukin-10 in the Middle Ear in Chronic Otitis Media With Effusion in Children With and Without Atopy [PDF]

open access: yesClinical and Experimental Otorhinolaryngology, 2016
Objectives The role of pro-inflammatory cytokines in the course of chronic otitis media with effusion (COME) has been documented. However, there are fewer studies on the action of anti-inflammatory cytokines in the middle ear. We sought determine whether
Beata Zielnik-Jurkiewicz   +1 more
doaj   +1 more source

IL1RN (interleukin 1 receptor antagonist) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2014
Review on IL1RN, with data on DNA/RNA, on the protein encoded and where the gene is implicated.
Gómez-Flores-Ramos, L   +2 more
openaire   +2 more sources

The interleukin-1 receptor antagonist influences interleukin-1 effects in rat and mouse

open access: yesMediators of Inflammation, 1992
In this work we have focused on the ability of interleukin-1 to induce an acute phase protein response and a degranulation of polymorphonuclear leukocytes in vivo.
P. Bjrök, K. Ohlsson
doaj   +1 more source

Rescued Chondrogenesis of Mesenchymal Stem Cells under Interleukin 1 Challenge by Foamyviral Interleukin 1 Receptor Antagonist Gene Transfer

open access: yesFrontiers in Pharmacology, 2017
Background: Mesenchymal stem cells (MSCs) and their chondrogenic differentiation have been extensively investigated in vitro as MSCs provide an attractive source besides chondrocytes for cartilage repair therapies.
Nicole Armbruster   +6 more
doaj   +1 more source

Restoration of the healing microenvironment in diabetic wounds with matrix-binding IL-1 receptor antagonist

open access: yesCommunications Biology, 2021
Tan, Lash et al. show that blocking the Interleukin-1 receptor promotes rapid wound closure in diabetic mice. They engineered a matrix binding form of Interleukin-1 receptor antagonist (IL-1Ra) that has the ability of precise localisation and retention ...
Jean L. Tan   +7 more
doaj   +1 more source

Interleukin-1 receptor antagonist levels predict favorable outcome after bermekimab, a first-in-class true human interleukin-1α antibody, in a phase III randomized study of advanced colorectal cancer

open access: yesOncoImmunology, 2019
Bermekimab is a true human monoclonal antibody that targets interleukin-1alpa (IL-1α), an inflammation-mediating alarmin. IL-1 receptor antagonist (IL-1Ra) is a natural molecule that blocks IL-1α activity by occupying the IL-1 receptor.
Razelle Kurzrock   +8 more
doaj   +1 more source

Studying the Pharmacokinetics of Interleukin-1RA Mutants

open access: yesBioscientific Review, 2019
The two antagonists for interleukin-1 (IL-1) system are IL-1α, and IL-1β. IL-1 receptor antagonist (IL-1RA) is another naturally occurring non-competitive antagonist. All three antagonists are bound to two receptors that are IL-R1 and IL-1R2.
Iqra Khuzaima   +4 more
doaj   +1 more source

Catecholamine stress alters neutrophil trafficking and impairs wound healing by β2-adrenergic receptor-mediated upregulation of IL-6. [PDF]

open access: yes, 2014
Stress-induced hormones can alter the inflammatory response to tissue injury; however, the precise mechanism by which epinephrine influences inflammatory response and wound healing is not well defined.
Byrne, Barbara A   +7 more
core   +2 more sources

Home - About - Disclaimer - Privacy